AIQ GLOBAL INC

MADISON, WI · Founded 2019 · Medtech · Private

AI-powered software for automated analysis of theranostic PET/CT imaging in cancer treatment, quantifying tumor response, organ toxicity, and radiation dosimetry

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · aiq-solutions.com

Sector: Medtech
Headquarters: MADISON, WI
Founded: 2019
Latest Form D: $1.4M, Mar 2026
Total capital: $21.8M

Federal grants: $4.4M; 5 awards · 2020–2024; Rank in peer group#15 of 53
Private capital raised: $17.4M; 5 Form D · last Mar 2026; 7 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 2 pending · first 2026; Rank in peer group#23 of 53

Capital timeline

Latest events

Mar 2026Private capital raisedForm D · SEC · 5th filing$1.4M
Aug 2025Private capital raisedForm D · SEC · 4th filing$1M
Jul 2024Federal grantHealth and Human S · Phase II · Comprehensive Assessment of Cancer Theranostics Response$1.1M
Jun 2024Private capital raisedForm D · SEC · 3rd filing$2.3M
Sep 2023Federal grantHealth and Human S · Phase II · Comprehensive Assessment of Cancer Theranostics Response$882K
Jun 2023Federal grantHealth and Human S · Phase II · Comprehensive Assessment of Cancer Immunotherapy Response$979K
Apr 2022Federal grantHealth and Human S · Phase II · Comprehensive Assessment of Cancer Immunotherapy Response$1M
Oct 2021Private capital raisedForm D · SEC · 2nd filing$9.4M
Aug 2019Private capital raisedForm D · SEC · 1st filing$3.2M

Show 1 earlier federal award

Sep 2020Federal grantHealth and Human S · Phase I · Comprehensive Assessment of Cancer Immunotherapy Response$388K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 53 peers

Line = median

Medtech · Software

Federal grants#15 · top 28%
Granted patents#23 · top 43%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Robert JerajResearcherDirectorLinked by 1 patent
Alvin VitangcolDirectorNamed in SEC Form D filings
Andy R. MullerDirectorNamed in SEC Form D filings
Chris ParkerDirectorNamed in SEC Form D filings
Dona AlbertiExecutive Officer, Director, PromoterNamed in SEC Form D filings
Eli Blee-GoldmanExecutive OfficerNamed in SEC Form D filings

Show all 13 people

Eric HorlerExecutive Officer, DirectorNamed in SEC Form D filings
Glenn LiuDirector, PromoterNamed in SEC Form D filings
Gregg FergusDirectorNamed in SEC Form D filings
Guy StarbuckDirector, PromoterNamed in SEC Form D filings
Michael PartschDirectorNamed in SEC Form D filings
Richard R. LesniewskiDirectorNamed in SEC Form D filings
Rick LesniewskiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 3

Feb 24, 2026GrantedMethods And Systems For Assessing Treatment Of A Disease Based On Lesion FeaturesUSPTOUS 12,562,258
May 23, 2024PendingApparatus for Monitoring Treatment Side EffectsUSPTOApplication 18423413
PendingAssessment Of Disease TreatmentUSPTOApplication PCTUS2022037277

Therma Bright Inc.Similar federal contract value in Medtech · null in contracts
Veravas, Inc.Similar federal contract value in Medtech · null in contracts
Adaptiiv Medical Technologies US, Inc.Similar federal contract value in Medtech · null in contracts
Innovative Trauma Care Inc.Similar federal contract value in Medtech · null in contracts
VentriFlo, Inc.Similar federal contract value in Medtech · null in contracts
AlgoMedica, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.